Article info
PDFDiagnosis
Randomised controlled trial
Single HPV test not useful for predicting CIN2 or worse or for guiding choice of further investigations for women aged 20–59 presenting to NHS Cervical Screening Programme with borderline abnormalities or mild dyskaryosis
- Correspondence to Ned Powell
HPV Research Group, Obstetrics and Gynaecology, School of Medicine, Heath Park, Cardiff University, Cardiff CF14 4XN, UK; powellng{at}cf.ac.uk
Citation
Single HPV test not useful for predicting CIN2 or worse or for guiding choice of further investigations for women aged 20–59 presenting to NHS Cervical Screening Programme with borderline abnormalities or mild dyskaryosis
Publication history
- First published July 30, 2010.
Online issue publication
October 25, 2017
Article Versions
- You are viewing the most recent version of this article.
- Previous version (25 October 2017).
- latest version (25 October 2017).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions